Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




RYGB Patients Face Higher Risk of Additional Operations

By HospiMedica International staff writers
Posted on 02 Jan 2020
A new study suggests that patients undergoing vertical sleeve gastrectomy (VSG) have a lower risk of subsequent operative intervention than those undergoing Roux-en-Y gastric bypass (RYGB).

Researchers at Harvard Medical School (HMS; Boston, MA, USA), Wake Forest School of Medicine (Winston-Salem, NC, USA), and other institutions used data from a U.S. More...
national insurance claims database of adults who underwent a first RYGB or VSG procedure between January 1, 2010, and June 30, 2017. The final weighted matched sample included 4,476 patients undergoing RYGB and 8,551 patients undergoing VSG, with the primary outcome being any abdominal operative intervention after the index procedure. Secondary outcomes included biliary procedures, abdominal wall hernia repair, bariatric conversion or revision, other abdominal operations, and endoscopy and enteral access.

The results revealed that in patients followed up for up to four years after surgery, those undergoing VSG were less likely to have any subsequent operative intervention than matched patients undergoing RYGB. They were similarly less likely to undergo biliary procedures, abdominal wall hernia repair, other abdominal operations, and endoscopy or enteral access placed. The patients undergoing VSG were also more likely to undergo bariatric conversion or revision. The study was published on December 18, 2019, in JAMA Network Open.

“Patients undergoing VSG appeared to be less likely than matched patients undergoing RYGB to experience subsequent abdominal operative interventions, except for bariatric conversion or revision procedures,” concluded senior author James Wharam, BCh, MPH, of HMS, and colleagues. “Patients considering bariatric surgery should be aware of the increased risk of subsequent procedures associated with RYGB. It's important for patients to understand not only the many benefits of bariatric surgery, but also the risks, including the possible need for more surgery down the road.”

VSG is a restrictive form of weight loss surgery intended for the morbidly obese which reduces the size of the stomach by removing the lateral 2/3 of the stomach with a stapling device. While the stomach is drastically reduced in size, function is preserved, with no malabsorption of nutrients and supplements. The procedure avoids problems associated with bypass forms of weight loss surgery, including anemia, intestinal obstruction or blockage, osteoporosis, and protein and vitamin deficiency, and since about 100-200 ml of stomach capacity is maintained, there are very few restrictions on food consumption.

Related Links:
Harvard Medical School
Wake Forest School of Medicine



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Imaging Table
Stille imagiQ2
Medical Monitor
VITALMAX 4100SL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.